IN8bio, Inc. (INAB)
1.63
+0.05
(+3.16%)
USD |
NASDAQ |
May 11, 12:46
IN8bio Market Cap : 7.400M for May 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DiaMedica Therapeutics, Inc. | 342.70M |
| Calidi Biotherapeutics, Inc. | 2.134M |
| ACADIA Pharmaceuticals, Inc. | 3.783B |
| Alnylam Pharmaceuticals, Inc. | 38.75B |
| Amgen, Inc. | 177.84B |
Market Cap Related Metrics
| Price to Book Value | 0.3249 |
| Price | 1.63 |
| Earnings Yield | -175.1% |